Dr. Marcel Germain
Claim this profileDiex Recherche Sherbrooke Inc.
Studies Alzheimer's Disease
Studies Dementia
2 reported clinical trials
2 drugs studied
Affiliated Hospitals
More about Marcel Germain
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Marcel Germain has experience with
- Donanemab
- No Intervention
Breakdown of trials Marcel Germain has run
Alzheimer's Disease
Nervous System Disorders
Brain Diseases
Central Nervous System Disorders
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marcel Germain specialize in?
Marcel Germain focuses on Alzheimer's Disease and Dementia. In particular, much of their work with Alzheimer's Disease has involved donanemab patients, or patients who are undergoing treatment.
Is Marcel Germain currently recruiting for clinical trials?
No, Marcel Germain is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Marcel Germain has studied deeply?
Yes, Marcel Germain has studied treatments such as Donanemab, No Intervention.
What is the best way to schedule an appointment with Marcel Germain?
Apply for one of the trials that Marcel Germain is conducting.
What is the office address of Marcel Germain?
The office of Marcel Germain is located at: Diex Recherche Sherbrooke Inc., Sherbrooke, Quebec J1L 0H8 Canada. This is the address for their practice at the Diex Recherche Sherbrooke Inc..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.